RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 79 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,208,000 | -64.0% | 291,005 | 0.0% | 0.02% | -66.7% |
| Q1 2022 | $3,352,000 | -82.0% | 291,005 | -84.4% | 0.08% | -80.8% |
| Q4 2021 | $18,637,000 | -28.3% | 1,867,467 | -6.1% | 0.39% | -22.9% |
| Q3 2021 | $25,985,000 | -33.3% | 1,989,625 | 0.0% | 0.51% | -26.7% |
| Q2 2021 | $38,957,000 | -7.9% | 1,989,625 | 0.0% | 0.69% | -22.2% |
| Q1 2021 | $42,319,000 | -47.7% | 1,989,625 | -26.9% | 0.89% | -44.4% |
| Q4 2020 | $80,901,000 | +96.8% | 2,721,203 | +43.4% | 1.60% | +59.7% |
| Q3 2020 | $41,109,000 | -25.4% | 1,897,047 | -23.2% | 1.00% | -37.6% |
| Q2 2020 | $55,081,000 | +19.4% | 2,470,013 | -18.5% | 1.60% | +9.6% |
| Q1 2020 | $46,140,000 | -53.1% | 3,031,565 | -29.3% | 1.46% | -53.4% |
| Q4 2019 | $98,482,000 | +76.2% | 4,289,291 | +65.7% | 3.14% | +37.9% |
| Q3 2019 | $55,903,000 | +307.2% | 2,589,291 | +315.0% | 2.28% | +362.3% |
| Q2 2019 | $13,727,000 | +72.1% | 623,933 | +114.4% | 0.49% | +61.1% |
| Q1 2019 | $7,976,000 | +2.0% | 291,005 | 0.0% | 0.31% | -2.2% |
| Q4 2018 | $7,822,000 | -26.7% | 291,005 | -20.4% | 0.31% | -18.1% |
| Q3 2018 | $10,667,000 | -51.5% | 365,689 | -48.0% | 0.38% | -50.5% |
| Q2 2018 | $21,995,000 | +89.9% | 703,600 | +20.9% | 0.77% | +92.5% |
| Q1 2018 | $11,582,000 | -31.5% | 582,010 | 0.0% | 0.40% | -39.8% |
| Q4 2017 | $16,913,000 | – | 582,010 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 735,000 | $13,112,400 | 3.93% |
| NEA Management Company, LLC | 2,909,956 | $51,913,615 | 3.59% |
| Frazier Life Sciences Management, L.P. | 2,164,739 | $38,618,944 | 2.80% |
| RA Capital Management | 5,516,067 | $98,406,635 | 2.23% |
| Samsara BioCapital, LLC | 345,293 | $6,160,027 | 1.27% |
| Rock Springs Capital Management LP | 1,597,123 | $28,492,674 | 0.68% |
| Baker Brothers Advisors | 6,498,267 | $115,929,083 | 0.63% |
| HighVista Strategies LLC | 35,478 | $632,928 | 0.52% |
| Nan Fung Group Holdings Ltd | 32,520 | $580,157 | 0.40% |
| GREAT POINT PARTNERS LLC | 97,544 | $1,740,185 | 0.34% |